Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,897.50
+48.10
(+0.61%)
ASX 200
7,629.00
+42.00
(+0.55%)
AUD/USD
0.6612
+0.0040
(+0.61%)
OIL
77.99
-0.96
(-1.22%)
GOLD
2,310.10
+0.50
(+0.02%)
Bitcoin AUD
96,600.66
+7,267.66
(+8.14%)
Qualigen Therapeutics Inc (7R9.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.2600
+0.0100
(+4.00%)
At close: 07:26PM CEST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
5,654
Cost of revenue
-
-
4,303
4,332
Gross profit
-
-
680.801
1,321
Operating expenses
Research development
5,209
5,209
4,486
11,717
Selling general and administrative
6,096
6,096
10,275
12,268
Total operating expenses
11,305
11,305
14,761
23,984
Operating income or loss
-11,305
-11,305
-14,761
-22,663
Interest expense
1,525
1,525
34.397
-
Total other income/expenses net
349.776
349.776
907.203
4,729
Income before tax
-12,480
-12,480
-13,888
-17,892
Income tax expense
-4.793
-4.793
6.548
5.427
Income from continuing operations
-12,475
-12,475
-13,894
-17,897
Net income
-13,417
-13,417
-18,641
-17,897
Net income available to common shareholders
-13,417
-13,417
-18,641
-17,897
Basic EPS
-3.73
-2.65
-4.86
-6.10
Diluted EPS
-3.73
-2.65
-4.86
-6.10
Basic average shares
4,820
5,073
3,840
2,933
Diluted average shares
4,820
5,073
3,840
2,933
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.